Page last updated: 2024-12-07

1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Myristoyl-2-Palmitoyl-sn-glycero-3-Phosphocholine (MPPC): A Key Player in Membrane Research

1-Myristoyl-2-Palmitoyl-sn-glycero-3-Phosphocholine (MPPC) is a **phospholipid** that plays a crucial role in biological membranes.

**Here's a breakdown:**

* **Phospholipid:** A type of lipid (fat) molecule that forms the basic building blocks of cell membranes. These molecules are amphipathic, meaning they have both a hydrophilic (water-loving) head and a hydrophobic (water-repelling) tail.
* **1-Myristoyl-2-Palmitoyl:** This part refers to the fatty acid chains attached to the glycerol backbone of the molecule. Myristoyl indicates a saturated fatty acid with 14 carbons, while Palmitoyl indicates a saturated fatty acid with 16 carbons.
* **sn-glycero-3-phosphocholine:** This part specifies the glycerol backbone and the phosphate group attached to the third carbon of the glycerol molecule. The choline head group is attached to the phosphate.

**Why is MPPC important for research?**

MPPC is a key component of **cell membranes**, which are essential for maintaining cell structure, controlling the passage of molecules, and facilitating cellular processes. This makes it a crucial focus for research in various areas:

* **Membrane Dynamics:** MPPC plays a role in membrane fluidity, permeability, and the formation of lipid rafts - specialized domains within cell membranes. Understanding these aspects is essential for studying cellular signaling, protein trafficking, and disease development.
* **Drug Delivery:** The unique properties of MPPC make it a promising candidate for developing drug delivery systems. For instance, its amphipathic nature allows it to encapsulate drugs and transport them across cell membranes, enhancing drug efficacy and reducing side effects.
* **Biomaterial Development:** MPPC is used to develop biocompatible materials, like liposomes, which are used in various applications, including gene therapy, vaccine delivery, and targeted drug delivery.
* **Model Systems:** MPPC is often used as a model membrane system in laboratory settings to study the behavior of proteins and lipids. This helps researchers gain insights into the fundamental mechanisms of membrane function.

**In summary, MPPC is a vital component of cell membranes with significant implications for research in various fields, including cell biology, drug development, and biomaterial engineering.**

1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine : A phosphatidylcholine 30:0 in which the phosphatidyl acyl groups at positions 1 and 2 are myristoyl (tetradecanoyl) and palmitoyl (hexadecanoyl) respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID129657
CHEBI ID75062
SCHEMBL ID233979
MeSH IDM0228102

Synonyms (31)

Synonym
LMGP01010481
1-tetradecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine
pc(14:0/16:0)
mppc
69525-80-0
[(2r)-2-hexadecanoyloxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
1-tetradecanoyl-2-hexadecanoylphosphatidylcholine
CHEBI:75062
1-myristoyl-2-palmitoyl-gpc (14:0/16:0)
1-myristoyl-2-palmitoyl-gpc
(2r)-2-(hexadecanoyloxy)-3-(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
phosphatidylcholine(14:0/16:0)
gpc(14:0/16:0)
3,5,8-trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-9-oxo-7-(((1-oxotetradecyl)oxy)methyl)-, hydroxide, inner salt, 4-oxide, (r)-
1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine
unii-7fzr5fu8wu
1-myristoyl-2-palmitoylphosphatidylcholine
7fzr5fu8wu ,
pc 30:0
phosphatidylcholine(30:0)
SCHEMBL233979
RFVFQQWKPSOBED-PSXMRANNSA-N
14:0-16:0 pc
3,5,8-trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-9-oxo-7-[[(1-oxotetradecyl)oxy]methyl]-, inner salt, 4-oxide, (r)-
14:0-16:0 pc, 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine, powder
Q27145102
DTXSID10989493
(7r)-3,5,8-trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-9-oxo-7-[[(1-oxotetradecyl)oxy]methyl]-, inner salt, 4-oxide
(r)-2-(palmitoyloxy)-3-(tetradecanoyloxy)propyl(2-(trimethylammonio)ethyl)phosphate
3,5,8-trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-9-oxo-7-(((1-oxotetradecyl)oxy)methyl)-, inner salt, 4-oxide, (7r)-
BP-26325
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
phosphatidylcholine 30:0A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 30 carbons in total with 0 double bonds.
tetradecanoate esterA fatty acid ester obtained by condensation of the carboxy group of tetradecanoic acid (also known as myristic acid) with a hydroxy group of an alcohol or phenol.
1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholineA 1,2-diacyl-sn-glycero-3-phosphocholine where the acyl group at position 1 is unspecified while the acyl group at position 2 is palmitoyl.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Phosphatidylcholine biosynthesis PC(14:0/16:0)27
Phosphatidylcholine Biosynthesis PC(14:0/16:0)620
Phosphatidylethanolamine Biosynthesis PE(14:0/16:0)516
Phosphatidylcholine/Phosphatidylethanolamine Biosynthesis PC(14:0/16:0) | PE(14:0/16:0)617

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (36.36)18.2507
2000's2 (18.18)29.6817
2010's5 (45.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.28 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]